{"filing":{"accession_number":"0000885978-26-000045","cik":"0000885978","ticker":"USPH","company_name":"U S PHYSICAL THERAPY INC /NV","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-06","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/885978/000088597826000045/form8-k.htm"},"events":[{"id":26587,"run_id":24169,"accession_number":"0000885978-26-000045","anchor_item_number":"7.01","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses U.S. Physical Therapy's results for the three and six months ended June 30, 2026, presented via a conference call on August 6, 2026. The transcript includes detailed financial metrics (revenue of $214 million, adjusted EBITDA of $27.0 million, EPS of $0.25), operational performance (visits, net rates, margins), and forward guidance. This is a standard earnings release disclosure under Item 7.01 (Regulation FD Disclosure), furnished as Exhibit 99.1.","company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27761,"accession_number":"0000885978-26-000045","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses U.S. Physical Therapy's results for the three and six months ended June 30, 2026, presented via a conference call on August 6, 2026. The transcript includes detailed financial metrics (revenue of $214 million, adjusted EBITDA of $27.0 million, EPS of $0.25), operational performance (visits, net rates, margins), and forward guidance. This is a standard earnings release disclosure under Item 7.01 (Regulation FD Disclosure), furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:22:32.275498+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27761,"accession_number":"0000885978-26-000045","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses U.S. Physical Therapy's results for the three and six months ended June 30, 2026, presented via a conference call on August 6, 2026. The transcript includes detailed financial metrics (revenue of $214 million, adjusted EBITDA of $27.0 million, EPS of $0.25), operational performance (visits, net rates, margins), and forward guidance. This is a standard earnings release disclosure under Item 7.01 (Regulation FD Disclosure), furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:22:32.275498+00:00","company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","filing_date":"2026-08-10"}]}